Oaktree Capital

Superinvestor

Oaktree Capital Management LP

SEC CIK: 0000949509
Manager: Howard Marks
Style: Value
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

ZVSA holding history

ZyVersa Therapeutics, Inc. in every 13F filed by Oaktree Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ZVSA overview All 13F holders of ZVSA Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2022

Holdings of ZVSA by Oaktree Capital, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−200,000−100.0%	Sold out	Holders
Q3 2022	200,000	$2.00M	<0.1%	00.0%	Unchanged	Holders
Q2 2022	200,000	$1.99M	<0.1%	00.0%	Unchanged	Holders
Q1 2022	200,000	$1.98M	<0.1%	+200,000	New	Holders